Insider Transactions in Q2 2023 at Mind Medicine (Mind Med) Inc. (MNMD)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2023
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,502
-1.22%
|
$46,506
$3.2 P/Share
|
|
Jun 27
2023
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,783
-0.88%
|
$20,349
$3.2 P/Share
|
|
Jun 27
2023
|
Schond L. Greenway Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,635
-2.26%
|
$34,905
$3.2 P/Share
|
|
Jun 21
2023
|
David W Gryska |
BUY
Grant, award, or other acquisition
|
Direct |
13,851
+50.0%
|
-
|
|
Jun 21
2023
|
Andreas Krebs |
BUY
Grant, award, or other acquisition
|
Direct |
13,671
+47.51%
|
-
|
|
Jun 21
2023
|
Roger Crystal |
BUY
Grant, award, or other acquisition
|
Direct |
13,671
+41.06%
|
-
|
|
Jun 21
2023
|
Suzanne Louise Bruhn |
BUY
Grant, award, or other acquisition
|
Direct |
13,671
+41.06%
|
-
|
|
Jun 21
2023
|
Carol A Vallone |
BUY
Grant, award, or other acquisition
|
Direct |
13,671
+45.25%
|
-
|
|
Apr 13
2023
|
Mark Sullivan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+50.0%
|
-
|